Turning Point Brands
OrganizationRelationship Network
HOUSE_OVERSIGHT_024919.jpg
This document is page 103 of a financial report produced by Cowen on February 25, 2019. It displays 'Rating History' charts for three companies: GW Pharmaceuticals Plc, Tilray, and Turning Point Brands, showing stock prices versus target prices over time (2016-2019). The document is marked with the Bates stamp 'HOUSE_OVERSIGHT_024919' and notes it is intended for Michael Cella at Cowen.
HOUSE_OVERSIGHT_024917.jpg
This document is an addendum to a Cowen research report dated February 25, 2019, providing mandatory regulatory disclosures and certifications. It lists Canopy Growth, GW Pharmaceuticals, Tilray, and Turning Point Brands as subject companies and details Cowen's investment banking relationships, market making activities, and compensation policies related to these entities. The document also includes a standard disclaimer regarding the informational nature of the report, limitations of liability, and contact information for the compliance department.
HOUSE_OVERSIGHT_024912.jpg
This document is page 96 of a financial research report titled 'Cowen Collaborative Insights' dated February 25, 2019. It contains 'Figure 136 Cannabis Comp Table,' an appendix listing market data and valuations for various cannabis-related companies such as Aphria Inc, Aurora Cannabis Inc, and Level Brands Inc. The document bears a 'HOUSE_OVERSIGHT_024912' stamp, indicating it was part of a document production to the House Oversight Committee, likely obtained from the files of Michael Cella at Cowen.
HOUSE_OVERSIGHT_024875.jpg
This document is page 59 of a Cowen Collaborative Insights financial report dated February 25, 2019, analyzing the Cannabis/CBD market. It presents comparative financial data (Revenue, Gross Profit, and Gross Margin) for several companies including Charlotte's Web, CV Sciences, and Level Brands. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation document production.
HOUSE_OVERSIGHT_024874.jpg
This document is page 58 of a Cowen Collaborative Insights financial report dated February 25, 2019, analyzing the cannabis and CBD industry. It details strategic updates, retail distribution benchmarking (store counts), and revenue figures for companies including TGOD, HEXO, Neptune, Organigram, Charlotte's Web, and Tilray. While the content is strictly financial analysis, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024874', indicating it was part of a document production for a US House Oversight Committee investigation, likely related to broader financial inquiries.
HOUSE_OVERSIGHT_024872.jpg
This document is a page from a Cowen Collaborative Insights equity research report dated February 25, 2019. It analyzes several companies in the cannabis and tobacco sectors, including GTI, Khiron Life Sciences, Level Brands, Tilray, and Turning Point Brands, providing revenue figures, stock ratings, and acquisition details. The document bears a House Oversight Committee Bates stamp, suggesting it was included in document production for a congressional investigation, likely related to financial institutions, though the page itself contains no direct references to Jeffrey Epstein.
HOUSE_OVERSIGHT_024819.jpg
A Cowen equity research report titled 'Cowen's Collective View of CBD - Ahead of the Curve Series,' dated February 25, 2019. The document analyzes the U.S. CBD market, projecting a $16 billion opportunity by 2025, and discusses consumer trends, scientific understanding, and hemp cultivation. The document bears a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_024819) and a watermark indicating it was intended for Michael Cella at Cowen.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity